Mochida Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
11,171.00
8,052.00
6,160.00
9,044.00
14,591.00
11,900.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-18,525.00
-1,319.00
-15,140.00
-131.00
-4,317.00
-3,684.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-7,350.00
9,354.00
-7,480.00
7,297.00
7,459.00
9,198.00
Cash Flow from Investing Activities
-16,848.00
17,355.00
74.00
-2,949.00
-2,007.00
-880.00
Cash Flow from Financing Activities
7,033.00
-2,865.00
-6,393.00
-6,884.00
-5,956.00
-5,112.00
Net Cash Inflow / Outflow
-17,092.00
23,860.00
-13,720.00
-2,504.00
-473.00
3,197.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
73.00
16.00
79.00
32.00
31.00
-9.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Mochida Pharmaceutical Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
11171
13165
-1,994.00
-15.15%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-18525
-6559
-11,966.00
-182.44%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-7350
30429
-37,779.00
-124.15%
Cash Flow from Investing Activities
-16848
-25660
8,812.00
34.34%
Cash Flow from Financing Activities
7033
-6828
13,861.00
203.00%
Net Cash Inflow / Outflow
-17092
-649
-16,443.00
-2533.59%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
73
1410
-1,337.00
-94.82%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -178.58% vs 225.05% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
-7,350.00
9,354.00
-178.58%






